Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2828346rdf:typepubmed:Citationlld:pubmed
pubmed-article:2828346lifeskim:mentionsumls-concept:C0032143lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C0728940lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C0018284lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C0015252lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C0449297lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C0439590lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:2828346lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:2828346pubmed:issue4lld:pubmed
pubmed-article:2828346pubmed:dateCreated1988-3-7lld:pubmed
pubmed-article:2828346pubmed:abstractTextThe complete cDNA for human tissue-type plasminogen activator (t-PA) was cloned and sequenced. A mutant was constructed by using in vitro site-specific mutagenesis to delete the region encoding the growth factor domain (amino acids 51-87 inclusive). Normal and mutant t-PA species were produced using two mammalian expression systems (in human HeLa cells and mouse C127 cells). The clearance of mutant and normal t-PA from plasma was examined in vivo using a guinea pig model. Mutant t-PA derived from HeLa or C127 cells was cleared much more slowly than the cognate normal t-PA. The potential role of the growth factor domain in the recognition of t-PA by the hepatic clearance mechanism is discussed.lld:pubmed
pubmed-article:2828346pubmed:languageenglld:pubmed
pubmed-article:2828346pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2828346pubmed:citationSubsetIMlld:pubmed
pubmed-article:2828346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2828346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2828346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2828346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2828346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2828346pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2828346pubmed:statusMEDLINElld:pubmed
pubmed-article:2828346pubmed:monthFeblld:pubmed
pubmed-article:2828346pubmed:issn0021-9258lld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:RobinsonJ HJHlld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:ChapmanC GCGlld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:BrowneM JMJlld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:LawrenceG MGMlld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:CareyJ EJElld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:DodoTTlld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:EsmailAAlld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:ReavyBBlld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:EntwisleCClld:pubmed
pubmed-article:2828346pubmed:authorpubmed-author:TyrrellA WAWlld:pubmed
pubmed-article:2828346pubmed:issnTypePrintlld:pubmed
pubmed-article:2828346pubmed:day5lld:pubmed
pubmed-article:2828346pubmed:volume263lld:pubmed
pubmed-article:2828346pubmed:ownerNLMlld:pubmed
pubmed-article:2828346pubmed:authorsCompleteYlld:pubmed
pubmed-article:2828346pubmed:pagination1599-602lld:pubmed
pubmed-article:2828346pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:meshHeadingpubmed-meshheading:2828346-...lld:pubmed
pubmed-article:2828346pubmed:year1988lld:pubmed
pubmed-article:2828346pubmed:articleTitleA tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain.lld:pubmed
pubmed-article:2828346pubmed:affiliationBeecham Pharmaceuticals Research Division, Biosciences Research Centre, Epsom, Surrey, United Kingdom.lld:pubmed
pubmed-article:2828346pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2828346lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2828346lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2828346lld:pubmed